Incidence and risk factors for post-ERCP pancreatitis in chronic pancreatitis

被引:40
|
作者
Zhao, Zhen-Hua [1 ,2 ]
Hu, Liang-Hao [1 ]
Ren, Hong-Bo [3 ]
Zhao, An-Jing [1 ]
Qian, Yang-Yang [1 ]
Sun, Xiao-Tian [1 ]
Su, Song [1 ]
Zhu, Shu-Guang [1 ]
Yu, Jin [1 ]
Zou, Wen-Bin [1 ]
Guo, Xiao-Rong [1 ]
Wang, Lei [1 ]
Li, Zhao-Shen [1 ]
Liao, Zhuan [1 ]
机构
[1] Second Mil Med Univ, Natl Clin Res Ctr Digest Dis, Shanghai Inst Pancreat Dis, Dept Gastroenterol,Digest Endoscopy Ctr,Changhai, Shanghai, Peoples R China
[2] Jining 1 Peoples Hosp, Dept Gastroenterol, Jining, Shandong, Peoples R China
[3] Shandong Univ, Qilu Hosp, Dept Gastroenterol, Jinan, Shandong, Peoples R China
基金
中国国家自然科学基金;
关键词
M-ANNHEIM CLASSIFICATION; EUROPEAN-SOCIETY; COMPLICATIONS; SPHINCTEROTOMY; PROPHYLAXIS; MANAGEMENT;
D O I
10.1016/j.gie.2016.12.020
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aims: Almost all studies on post-ERCP pancreatitis (PEP) have mainly involved patients with biliary diseases rather than chronic pancreatitis (CP), and the concept that CP seems to be a protective factor associated with PEP has not been studied in detail. The aim of this study was to determine the incidence of PEP in patients with CP at different clinical stages and to identify the predictive and protective factors of PEP in a large cohort. Methods: In this observational cohort study, medical records of patients with CP (CP group) and biliary diseases (BD group) in a tertiary hospital from January 2011 to May 2015 were examined. The difference in the incidence of PEP between CP group and BD group and the risk of PEP at different clinical stages of CP were calculated by the chi(2) test or the Fisher exact test. The predictive and protective factors for PEP were investigated by univariate and multivariate analysis. Results: In total, 2028 ERCP procedures were performed in 1301 patients with CP and 2000 procedures in 1655 patients with BD. The overall incidence of PEP in CP group (4.5%) was similar to that in the BD group (4.8%; P = .747). However, CP patients had significantly lower rates of moderate and severe attacks (0% vs 1.3%, P < .01). According to the M-ANNHEIM classification, the PEP incidences of CP at stages 0, I, II, III, and IV were 4.4%, 5.1%, 3.8%, 2.0%, and 2.0%, respectively. CP patients at stage Ia had the highest PEP incidence (8.0%) among all CP patients, significantly higher than that at stages Ib + Ic (3.9%) and II (3.8%). Female gender, history of acute pancreatitis, and prior PEP were independent risk factors of PEP, whereas extracorporeal shock wave lithotripsy was a protective factor. Conclusions: Compared with BD patients, CP patients had similar incidence of PEP overall but lower grades of severity. The incidence of PEP in CP patients decreased significantly with disease progression.
引用
收藏
页码:519 / U355
页数:7
相关论文
共 50 条
  • [21] Risk factors for post-ERCP pancreatitis: A prospective multicenter study
    Cheng, CL
    Sherman, S
    Watkins, JL
    Barnett, J
    Freeman, M
    Geenen, J
    Ryan, M
    Parker, H
    Frakes, JT
    Fogel, EL
    Silverman, WB
    Dua, KS
    Aliperti, G
    Yakshe, P
    Uzer, M
    Jones, W
    Goff, J
    Lazzell-Pannell, L
    Rashdan, A
    Temkit, M
    Lehman, GA
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (01): : 139 - 147
  • [22] Are drugs a risk factor of post-ERCP pancreatitis?
    Perney, P
    Berthier, E
    Pageaux, GP
    Hillaire-Buys, D
    Roques, V
    Fabbro-Peray, P
    Melki, M
    Hanslik, B
    Bauret, P
    Larrey, D
    Blayac, JP
    Blanc, F
    GASTROINTESTINAL ENDOSCOPY, 2003, 58 (05) : 696 - 700
  • [23] Guidewire cannulation and the risk of post-ERCP pancreatitis
    Menon, Shyam
    GASTROINTESTINAL ENDOSCOPY, 2012, 76 (02) : 468 - 468
  • [24] Risk of post-ERCP pancreatitis declines with age
    Old, Oliver
    Hardy, Thomas
    Hewin, David
    Barr, Hugh
    Brown, Jonathan
    GASTROINTESTINAL ENDOSCOPY, 2016, 83 (06) : 1307 - 1308
  • [25] The Effect of Medication on the Risk of Post-ERCP Pancreatitis
    Koubi, Sharon
    Borgaonkar, Mark
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 : S526 - S526
  • [26] Lowering the risk of post-ERCP pancreatitis Response
    Inamdar, Sumant
    Sejpal, Divyesh V.
    Trindade, Arvind J.
    GASTROINTESTINAL ENDOSCOPY, 2017, 85 (03) : 689 - 690
  • [27] Preventing post-ERCP pancreatitis
    Enns, Robert
    Lee, Sunny
    GASTROINTESTINAL ENDOSCOPY, 2013, 78 (06) : 851 - 853
  • [28] Prophylaxis of Post-ERCP Pancreatitis
    Dolak W.
    Journal für Gastroenterologische und Hepatologische Erkrankungen, 2021, 19 (1) : 18 - 21
  • [29] Prevention of Post-ERCP Pancreatitis
    Jennifer Maranki
    Paul Yeaton
    Current Gastroenterology Reports, 2013, 15 (11)
  • [30] Octreotide and post-ERCP pancreatitis
    Kaya, Ekrern
    GASTROINTESTINAL ENDOSCOPY, 2007, 66 (02) : 420 - 421